CSS LLC’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

CSS LLC’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-38,843	Closed	-$896K	–	1240
2020 Q4	$896K	Buy	+38,843	New	+$492K	0.03%	344

CSS LLC's PRVL Position: Q1 2021 in Review

CSS LLC sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 38,843 shares — an estimated $896K sold.

CSS LLC first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $896K in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

CSS LLC reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
CSS LLC sold 38,843 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $896K.
CSS LLC first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
CSS LLC's Prevail Therapeutics Inc. Common Stock position peaked at $896K in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on CSS LLC's 13F filing for Q1 2021, filed 17 May 2021.